The Latest Cardiac and Vascular News
Over 90 patients have received the Aeson® artificial heart since the first implant in 2013, including 42 in 2024. 2024 Sales of €7 million (a 2.5-fold increase vs 2023). Cash burn reduced by over 20% vs 2023. 50 hospitals trained in Aeson® implants internationally1. Successful first “Aeson® User Meeting” and […]
BURLINGTON, Mass.–(BUSINESS WIRE)–Cardurion Pharmaceuticals, Inc. (“Cardurion”), a clinical-stage biotechnology company discovering and developing new therapeutic approaches for the treatment of cardiovascular diseases, today announced that Charlotte (Charlie) Newman has joined the company as Chief Business Officer. A biopharmaceutical industry executive with over 25 years of industry experience, Ms. Newman most recently […]
IRVINE, Calif., Jan. 8, 2025 /PRNewswire/ — Relief Cardiovascular, an inQB8 Medical Technologies portfolio company pioneering innovative solutions for the management of heart failure, today announced the closing of a $12M Series A financing. The funding round was co-led by Broadview…
Acquisition to expand cardiovascular portfolio with complementary and differentiated calcium modification platform, furthering company’s strategy to address coronary and peripheral disease MARLBOROUGH, Mass., Jan. 8, 2025 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today…
DUBLIN–(BUSINESS WIRE)–FIRE1, a leading connected medical device solutions company, today announced the successful completion of a $120 million financing round to accelerate the company’s mission to transform the lives of millions of people living with heart failure. “From the beginning, our team has been driven by two core goals: creating […]
January 07, 2025 07:30 AM Eastern Standard Time KING OF PRUSSIA, Pa.–(BUSINESS WIRE)–XyloCor Therapeutics, Inc., (“XyloCor”), a clinical stage biopharmaceutical company developing novel gene therapies for cardiovascular disease, today announced the completion of a $67.5 million Series B financing. New investment will support a randomized, double-blind Phase 2b clinical trial […]
CAMPBELL, Calif.–(BUSINESS WIRE)–Simpson Interventions, Inc., a pioneering medical technology company, specializing in cardiovascular interventional devices, today announced achievement of major development milestones. Its truly unique Acolyte™ Image-Guided Crossing and Re-Entry Catheter System has been granted an Investigational Device Exemption by the U.S. Food and Drug Administration (FDA), after having been […]
SAN JOSE, Calif.–(BUSINESS WIRE)–Evident Vascular, Inc., a medical technology startup backed by Vensana Capital® developing an AI-powered next-generation intravascular ultrasound (IVUS) platform, is pleased to announce the appointment of Scott R. Ward to its Board of Directors. “We are thrilled to welcome Scott to the Evident Vascular Board” Post this […]
Portage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) — Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. (NASDAQ: NARI) for $80 per share in cash, representing a total fully diluted equity value of approximately $4.9 billion. Inari, which was founded in 2011, will bring a leading peripheral vascular position in the fast-growing segment of venous thromboembolism (VTE) to Stryker. Inari’s innovative product portfolio is highly complementary to Stryker’s Neurovascular business and includes mechanical thrombectomy solutions for peripheral vascular diseases such as deep vein thrombosis and pulmonary embolism.
Seasoned MedTech Executive to Lead U.S. Launch of Vitestro’s Autonomous Robotic Blood-Draw Device UTRECHT, Netherlands, Jan. 6, 2025 /PRNewswire/ — Vitestro, a pioneer in autonomous robotic venous access and blood drawing, today announced the appointment of Bob Gerberich as Chief…
